Safety Shot To Develop Detox Product For Alcohol Poising, Plans To File IND With U.S. FDA
Portfolio Pulse from Bill Haddad
Safety Shot is planning to develop a detox product for alcohol poisoning and intends to file an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA).
September 18, 2023 | 12:04 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Safety Shot's plans to develop a detox product for alcohol poisoning and file an IND with the FDA could potentially boost its stock in the short term.
The development of a new product and the filing of an IND with the FDA are significant steps for a pharmaceutical company. If successful, these actions could lead to increased revenues and a potential rise in stock price. However, the process is subject to regulatory approval and there is always a risk of failure.
CONFIDENCE 70
IMPORTANCE 80
RELEVANCE 100